Analgesics
Antiandrogens
Antihistamines
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
PPIs
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
 
next
study
previous
study
c19early.org COVID-19 treatment researchQuercetinQuercetin (more..)
Melatonin Meta
Metformin Meta
Antihistamines Meta
Azvudine Meta Molnupiravir Meta
Bromhexine Meta
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta PPIs Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis       

Quercetin improves and protects Calu-3 airway epithelial barrier function

DiGuilio et al., Frontiers in Cell and Developmental Biology, doi:10.3389/fcell.2023.1271201
Nov 2023  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
Quercetin for COVID-19
24th treatment shown to reduce risk in July 2021, now with p = 0.002 from 12 studies.
No treatment is 100% effective. Protocols combine treatments.
5,100+ studies for 112 treatments. c19early.org
In Vitro analysis of quercetin on airway epithelial barrier function using the Calu-3 cell culture model. Results show that quercetin increases transepithelial electrical resistance and decreases transepithelial leaks, indicating improved barrier function. These effects are concentration-dependent and show a biphasic time course. Quercetin also alters tight junctional protein composition, partially inhibits cell replication, and decreases linear junctional density, contributing to improved barrier function. Furthermore, quercetin effectively reduces barrier compromise caused by the pro-inflammatory cytokine TNF-α, partly due to its action in reducing TNF-α-induced ERK 1/2 phosphorylation and altering the tight junctional complex. The study suggests quercetin’s potential in airway diseases involving barrier compromise, like COVID-19, due to its capability to improve epithelial barrier function and protect against inflammatory cytokines.
Bioavailability. Quercetin has low bioavailability and studies typically use advanced formulations to improve bioavailability which may be required to reach therapeutic concentrations.
73 preclinical studies support the efficacy of quercetin for COVID-19:
In Silico studies predict inhibition of SARS-CoV-2, or minimization of side effects, with quercetin or metabolites via binding to the spikeA,3,9,10,22,24,25,30,38,39,41,42,62-64, MproB,3,7,9,11,13,15,17,18,20,23,24,30,34,36-38,42,43,45,63-65, RNA-dependent RNA polymeraseC,1,3,9,32,64, PLproD,3,37,45, ACE2E,22,23,28,37,41,63, TMPRSS2F,22, nucleocapsidG,3, helicaseH,3,29,34, endoribonucleaseI,39, NSP16/10J,6, cathepsin LK,26, Wnt-3L,22, FZDM,22, LRP6N,22, ezrinO,40, ADRPP,38, NRP1Q,41, EP300R,16, PTGS2S,23, HSP90AA1T,16,23, matrix metalloproteinase 9U,31, IL-6V,21,35, IL-10W,21, VEGFAX,35, and RELAY,35 proteins. In Vitro studies demonstrate inhibition of the MproB,15,46,51,59 protein, and inhibition of spike-ACE2 interactionZ,47. In Vitro studies demonstrate efficacy in Calu-3AA,50, A549AB,21, HEK293-ACE2+AC,58, Huh-7AD,25, Caco-2AE,49, Vero E6AF,19,42,49, mTECAG,52, and RAW264.7AH,52 cells. Animal studies demonstrate efficacy in K18-hACE2 miceAI,55, db/db miceAJ,52,61, BALB/c miceAK,60, and rats66. Quercetin reduced proinflammatory cytokines and protected lung and kidney tissue against LPS-induced damage in mice60, inhibits LPS-induced cytokine storm by modulating key inflammatory and antioxidant pathways in macrophages5, and inhibits SARS-CoV-2 ORF3a ion channel activity, which contributes to viral pathogenicity and cytotoxicity54.
a. The trimeric spike (S) protein is a glycoprotein that mediates viral entry by binding to the host ACE2 receptor, is critical for SARS-CoV-2's ability to infect host cells, and is a target of neutralizing antibodies. Inhibition of the spike protein prevents viral attachment, halting infection at the earliest stage.
b. The main protease or Mpro, also known as 3CLpro or nsp5, is a cysteine protease that cleaves viral polyproteins into functional units needed for replication. Inhibiting Mpro disrupts the SARS-CoV-2 lifecycle within the host cell, preventing the creation of new copies.
c. RNA-dependent RNA polymerase (RdRp), also called nsp12, is the core enzyme of the viral replicase-transcriptase complex that copies the positive-sense viral RNA genome into negative-sense templates for progeny RNA synthesis. Inhibiting RdRp blocks viral genome replication and transcription.
d. The papain-like protease (PLpro) has multiple functions including cleaving viral polyproteins and suppressing the host immune response by deubiquitination and deISGylation of host proteins. Inhibiting PLpro may block viral replication and help restore normal immune responses.
e. The angiotensin converting enzyme 2 (ACE2) protein is a host cell transmembrane protein that serves as the cellular receptor for the SARS-CoV-2 spike protein. ACE2 is expressed on many cell types, including epithelial cells in the lungs, and allows the virus to enter and infect host cells. Inhibition may affect ACE2's physiological function in blood pressure control.
f. Transmembrane protease serine 2 (TMPRSS2) is a host cell protease that primes the spike protein, facilitating cellular entry. TMPRSS2 activity helps enable cleavage of the spike protein required for membrane fusion and virus entry. Inhibition may especially protect respiratory epithelial cells, buy may have physiological effects.
g. The nucleocapsid (N) protein binds and encapsulates the viral genome by coating the viral RNA. N enables formation and release of infectious virions and plays additional roles in viral replication and pathogenesis. N is also an immunodominant antigen used in diagnostic assays.
h. The helicase, or nsp13, protein unwinds the double-stranded viral RNA, a crucial step in replication and transcription. Inhibition may prevent viral genome replication and the creation of new virus components.
i. The endoribonuclease, also known as NendoU or nsp15, cleaves specific sequences in viral RNA which may help the virus evade detection by the host immune system. Inhibition may hinder the virus's ability to mask itself from the immune system, facilitating a stronger immune response.
j. The NSP16/10 complex consists of non-structural proteins 16 and 10, forming a 2'-O-methyltransferase that modifies the viral RNA cap structure. This modification helps the virus evade host immune detection by mimicking host mRNA, making NSP16/10 a promising antiviral target.
k. Cathepsin L is a host lysosomal cysteine protease that can prime the spike protein through an alternative pathway when TMPRSS2 is unavailable. Dual targeting of cathepsin L and TMPRSS2 may maximize disruption of alternative pathways for virus entry.
l. Wingless-related integration site (Wnt) ligand 3 is a host signaling molecule that activates the Wnt signaling pathway, which is important in development, cell growth, and tissue repair. Some studies suggest that SARS-CoV-2 infection may interfere with the Wnt signaling pathway, and that Wnt3a is involved in SARS-CoV-2 entry.
m. The frizzled (FZD) receptor is a host transmembrane receptor that binds Wnt ligands, initiating the Wnt signaling cascade. FZD serves as a co-receptor, along with ACE2, in some proposed mechanisms of SARS-CoV-2 infection. The virus may take advantage of this pathway as an alternative entry route.
n. Low-density lipoprotein receptor-related protein 6 is a cell surface co-receptor essential for Wnt signaling. LRP6 acts in tandem with FZD for signal transduction and has been discussed as a potential co-receptor for SARS-CoV-2 entry.
o. The ezrin protein links the cell membrane to the cytoskeleton (the cell's internal support structure) and plays a role in cell shape, movement, adhesion, and signaling. Drugs that occupy the same spot on ezrin where the viral spike protein would bind may hindering viral attachment, and drug binding could further stabilize ezrin, strengthening its potential natural capacity to impede viral fusion and entry.
p. The Adipocyte Differentiation-Related Protein (ADRP, also known as Perilipin 2 or PLIN2) is a lipid droplet protein regulating the storage and breakdown of fats in cells. SARS-CoV-2 may hijack the lipid handling machinery of host cells and ADRP may play a role in this process. Disrupting ADRP's interaction with the virus may hinder the virus's ability to use lipids for replication and assembly.
q. Neuropilin-1 (NRP1) is a cell surface receptor with roles in blood vessel development, nerve cell guidance, and immune responses. NRP1 may function as a co-receptor for SARS-CoV-2, facilitating viral entry into cells. Blocking NRP1 may disrupt an alternative route of viral entry.
r. EP300 (E1A Binding Protein P300) is a transcriptional coactivator involved in several cellular processes, including growth, differentiation, and apoptosis, through its acetyltransferase activity that modifies histones and non-histone proteins. EP300 facilitates viral entry into cells and upregulates inflammatory cytokine production.
s. Prostaglandin G/H synthase 2 (PTGS2, also known as COX-2) is an enzyme crucial for the production of inflammatory molecules called prostaglandins. PTGS2 plays a role in the inflammatory response that can become severe in COVID-19 and inhibitors (like some NSAIDs) may have benefits in dampening harmful inflammation, but note that prostaglandins have diverse physiological functions.
t. Heat Shock Protein 90 Alpha Family Class A Member 1 (HSP90AA1) is a chaperone protein that helps other proteins fold correctly and maintains their stability. HSP90AA1 plays roles in cell signaling, survival, and immune responses. HSP90AA1 may interact with numerous viral proteins, but note that it has diverse physiological functions.
u. Matrix metalloproteinase 9 (MMP9), also called gelatinase B, is a zinc-dependent enzyme that breaks down collagen and other components of the extracellular matrix. MMP9 levels increase in severe COVID-19. Overactive MMP9 can damage lung tissue and worsen inflammation. Inhibition of MMP9 may prevent excessive tissue damage and help regulate the inflammatory response.
v. The interleukin-6 (IL-6) pro-inflammatory cytokine (signaling molecule) has a complex role in the immune response and may trigger and perpetuate inflammation. Elevated IL-6 levels are associated with severe COVID-19 cases and cytokine storm. Anti-IL-6 therapies may be beneficial in reducing excessive inflammation in severe COVID-19 cases.
w. The interleukin-10 (IL-10) anti-inflammatory cytokine helps regulate and dampen immune responses, preventing excessive inflammation. IL-10 levels can also be elevated in severe COVID-19. IL-10 could either help control harmful inflammation or potentially contribute to immune suppression.
x. Vascular Endothelial Growth Factor A (VEGFA) promotes the growth of new blood vessels (angiogenesis) and has roles in inflammation and immune responses. VEGFA may contribute to blood vessel leakiness and excessive inflammation associated with severe COVID-19.
y. RELA is a transcription factor subunit of NF-kB and is a key regulator of inflammation, driving pro-inflammatory gene expression. SARS-CoV-2 may hijack and modulate NF-kB pathways.
z. The interaction between the SARS-CoV-2 spike protein and the human ACE2 receptor is a primary method of viral entry, inhibiting this interaction can prevent the virus from attaching to and entering host cells, halting infection at an early stage.
aa. Calu-3 is a human lung adenocarcinoma cell line with moderate ACE2 and TMPRSS2 expression and SARS-CoV-2 susceptibility. It provides a model of the human respiratory epithelium, but many not be ideal for modeling early stages of infection due to the moderate expression levels of ACE2 and TMPRSS2.
ab. A549 is a human lung carcinoma cell line with low ACE2 expression and SARS-CoV-2 susceptibility. Viral entry/replication can be studied but the cells may not replicate all aspects of lung infection.
ac. HEK293-ACE2+ is a human embryonic kidney cell line engineered for high ACE2 expression and SARS-CoV-2 susceptibility.
ad. Huh-7 cells were derived from a liver tumor (hepatoma).
ae. Caco-2 cells come from a colorectal adenocarcinoma (cancer). They are valued for their ability to form a polarized cell layer with properties similar to the intestinal lining.
af. Vero E6 is an African green monkey kidney cell line with low/no ACE2 expression and high SARS-CoV-2 susceptibility. The cell line is easy to maintain and supports robust viral replication, however the monkey origin may not accurately represent human responses.
ag. mTEC is a mouse tubular epithelial cell line.
ah. RAW264.7 is a mouse macrophage cell line.
ai. A mouse model expressing the human ACE2 receptor under the control of the K18 promoter.
aj. A mouse model of obesity and severe insulin resistance leading to type 2 diabetes due to a mutation in the leptin receptor gene that impairs satiety signaling.
ak. A mouse model commonly used in infectious disease and cancer research due to higher immune response and susceptibility to infection.
DiGuilio et al., 23 Nov 2023, peer-reviewed, 8 authors.
In Vitro studies are an important part of preclinical research, however results may be very different in vivo.
This PaperQuercetinAll
Quercetin improves and protects Calu-3 airway epithelial barrier function
K M Diguilio, E Rybakovsky, M C Valenzano, H H Nguyen, E A Del Rio, E Newberry, R Spadea, J M Mullin
Frontiers in Cell and Developmental Biology, doi:10.3389/fcell.2023.1271201
Introduction: In light of the impact of airway barrier leaks in COVID-19 and the significance of vitamin D in COVID-19 outcomes, including airway barrier protection, we investigated whether the very common dietary flavonoid quercetin could also be efficacious in supporting airway barrier function. Methods: To address this question, we utilized the widely used airway epithelial cell culture model, Calu-3. Results: We observed that treating Calu-3 cell layers with quercetin increased transepithelial electrical resistance while simultaneously reducing transepithelial leaks of 14C-D-mannitol (Jm) and 14C-inulin. The effects of quercetin were concentration-dependent and exhibited a biphasic time course. These effects of quercetin occurred with changes in tight junctional protein composition as well as a partial inhibition of cell replication that resulted in decreased linear junctional density. Both of these effects potentially contribute to improved barrier function. Quercetin was equally effective in reducing the barrier compromise caused by the pro-inflammatory cytokine TNF-α, an action that seemed to derive, in part, from reducing the elevation of ERK 1/2 caused by TNF-α. Discussion: Quercetin improved Calu-3 barrier function and reduced TNF-α-induced barrier compromise, mediated in part by changes in the tight junctional complex.
Data availability statement The raw data supporting the conclusion of this article will be made available by the authors, without undue reservation. Ethics statement Ethical approval was not required for the studies on humans in accordance with the local legislation and institutional requirements because only commercially available established cell lines were used. Author contributions KD: writing-original draft, writing-review and editing, and investigation. ER: investigation and writing-review and editing. MV: investigation and writing-review and editing. HN: investigation and writing-review and editing. ED: investigation and writing-review and editing. EN: investigation and writing-review and editing. RS: investigation and writing-review and editing. JM: writing-review and editing, conceptualization, supervision, and writing-original draft. Conflict of interest The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. Publisher's note All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors, and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher. Supplementary material The Supplementary Material for this article can be..
References
Al-Khayri, Sahana, Nagella, Joseph, Alessa et al., Flavonoids as potential anti-inflammatory molecules: a review, Molecules, doi:10.3390/molecules27092901
Amasheh, Andres, Amasheh, Fromm, Schulzke, Barrier effects of nutritional factors, Ann. N. Y. Acad. Sci, doi:10.1111/j.1749-6632.2009.04063x
Amasheh, Luettig, Amasheh, Zeitz, Fromm et al., Effects of quercetin studied in colonic HT-29/B6 cells and rat intestine in vitro, Ann. N. Y. Acad. Sci, doi:10.1111/j.1749-6632.2012.06609x
Amasheh, Schlichter, Amasheh, Mankertz, Zeitz et al., Quercetin enhances epithelial barrier function and increases claudin-4 expression in Caco-2 cells, J. Nutr, doi:10.1093/jn/138.6.1067
Amevor, Cui, Du, Ning, Deng et al., Supplementation of dietary quercetin and vitamin E promotes the intestinal structure and immune barrier integrity in aged breeder hens, Front. Immunol, doi:10.3389/fimmu.2022.860889
Bae, Choe, Holick, Lim, Association of vitamin D status with COVID-19 and its severity: vitamin D and COVID-19: a narrative review, Rev. Endocr. Metab. Disord, doi:10.1007/s11154-021-09705-6
Burton, A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid, Biochem. J, doi:10.1042/bj0620315
Callaghan, Ferrick, Rybakovsky, Thomas, Mullin, Epithelial barrier function properties of the 16HBE14o-human bronchial epithelial cell culture model, Biosci. Rep, doi:10.1042/BSR20201532
Carrasco-Pozo, Morales, Gotteland, Polyphenols protect the epithelial barrier function of Caco-2 cells exposed to indomethacin through the modulation of occludin and zonula occludens-1 expression, J. Agric. Food Chem, doi:10.1021/jf400150p
Chuenkitiyanon, Pengsuparp, Jianmongkol, Protective effect of quercetin on hydrogen peroxide-induced tight junction disruption, Int. J. Toxicol, doi:10.1177/1091581810366487
Crews, Alessandrini, Erikson, Erks: their fifteen minutes has arrived, Cell Growth Differ
Diguilio, Rybakovsky, Abdavies, Chamoun, Flounders et al., Micronutrient improvement of epithelial barrier function in various disease states: a case for adjuvant therapy, Int. J. Mol. Sci, doi:10.3390/ijms23062995
Fan, Li, Zhang, Zhao, Wang, Pretreatment of IEC-6 cells with quercetin and myricetin resists the indomethacin-induced barrier dysfunction via attenuating the calcium-mediated JNK/Src activation, Food Chem. Toxicol, doi:10.1016/j.fct.2020.111896
Fan, Zhang, Zhao, Zhang, The impact of heat treatment of quercetin and myricetin on their activities to alleviate the acrylamide-induced cytotoxicity and barrier loss in IEC-6 cells, Plant Foods Hum. Nutr, doi:10.1007/s11130-022-00994-z
Formica, Regelson, Review of the biology of Quercetin and related bioflavonoids, Food Chem. Toxicol, doi:10.1016/0278-6915(95)00077-1
Gamero-Estevez, Andonian, Jean-Claude, Gupta, Ryan, Temporal effects of quercetin on tight junction barrier properties and claudin expression and localization in MDCK II cells, Int. J. Mol. Sci, doi:10.3390/ijms20194889
Gao, Raduka, Rezaee, Vitamin D 3 protects against respiratory syncytial virus-induced barrier dysfunction in airway epithelial cells via PKA signaling pathway, Eur. J. Cell Biol, doi:10.1016/j.ejcb.2023.151336
Guttman, Finlay, Tight junctions as targets of infectious agents, Biochim. Biophys. Acta, doi:10.1016/j.bbamem.2008.10.028
Kevil, Oshima, Alexander, Coe, Alexander, H(2) O(2)-mediated permeability: role of MAPK and occludin, Am. J. Physiol. Cell Physiol, doi:10.1152/ajpcell.2000.279.1.C21
Kreuzfelder, Joka, Keinecke, Obertacke, Schmit-Neuerburg et al., Adult respiratory distress syndrome as a specific manifestation of a general permeability defect in trauma patients, Am. Rev. Respir. Dis, doi:10.1164/ajrccm/137.1.95
Leyva-López, Gutierrez-Grijalva, Ambriz-Perez, Heredia, Flavonoids as cytokine modulators: a possible therapy for inflammation-related diseases, Int. J. Mol. Sci, doi:10.3390/ijms17060921
Li, Mao, Gu, Wei, Gong, Quercetin protects retina external barrier from oxidative stress injury by promoting autophagy, Cutan. Ocul. Toxicol, doi:10.1080/15569527.2020.1860082
Martínez, Mijares, De Sanctis, Effects of flavonoids and its derivatives on immune cell responses. Recent Pat, Inflamm. Allergy Drug Discov, doi:10.2174/1872213X13666190426164124
Mercado, Valenzano, Jeffers, Sedlak, Cugliari et al., Enhancement of tight junctional barrier function by micronutrients: compound-specific effects on permeability and claudin composition, PLoS One, doi:10.1371/journal.pone.0078775
Mullin, Ginanni, Laughlin, Protein kinase C activation increases transepithelial transport of biologically active insulin, Cancer Res
Mullin, Kampherstein, Laughlin, Clarkin, Miller et al., Overexpression of protein kinase C-delta increases tight junction permeability in LLC-PK1 epithelia, Am. J. Physiol, doi:10.1152/ajpcell.1998.275.2.C544
Mullin, Mcginn, The phorbol ester, TPA, increases transepithelial epidermal growth factor flux, FEBS Lett, doi:10.1016/0014-5793(87)80956-0
Nakashima, Hisada, Goda, Tenno, Kotake et al., Opposing effect of naringenin and quercetin on the junctional compartment of MDCK II cells to modulate the tight junction, Nutrients, doi:10.3390/nu12113285
Noureddine, Chalubinski, Wawrzyniak, The role of defective epithelial barriers in allergic lung disease and asthma development, J. Asthma Allergy, doi:10.2147/JAA.S324080
Petecchia, Sabatini, Usai, Caci, Varesio et al., Cytokines induce tight junction disassembly in airway cells via an EGFR-dependent MAPK/ERK1/2-pathway, Lab. Invest, doi:10.1038/labinvest.2012.67
Rabito, Reassembly of the occluding junctions in a renal cell line with characteristics of proximal tubular cells, Am. J. Physiol, doi:10.1152/ajprenal.1986.251.6.F978
Rasch, Schmidle, Sancak, Herner, Huberle et al., Increased extravascular lung water index (EVLWI) reflects rapid non-cardiogenic oedema and mortality in COVID-19 associated ARDS, Sci. Rep, doi:10.1038/s41598-021-91043-3
Rastogi, Bhansali, Khare, Suri, Yaddanapudi et al., Short term, high-dose vitamin D supplementation for COVID-19 disease: a randomised, placebo-controlled, study (SHADE study), Postgrad. Med. J, doi:10.1136/postgradmedj-2020-139065
Rybakovsky, Diguilio, Valenzano, Geagan, Pham et al., Calcitriol modifies tight junctions, improves barrier function, and reduces TNF-α-induced barrier leak in the human lung-derived epithelial cell culture model, 16HBE 14o, Physiol. Rep, doi:10.14814/phy2.15592
Rybakovsky, Valenzano, Deis, Diguilio, Thomas et al., Improvement of human-oral-epithelial-barrier function and of tight junctions by micronutrients, J. Agric. Food Chem, doi:10.1021/acs.jafc.7b04203
Sharma, Tripathi, Sharma, Dixit, Flavonoids modulate tight junction barrier functions in hyperglycemic human intestinal Caco-2 cells, Nutrition, doi:10.1016/j.nut.2020.110792
Soler, Miller, Laughlin, Carp, Klurfeld et al., Increased tight junctional permeability is associated with the development of colon cancer, Carcinogenesis, doi:10.1093/carcin/20.8.1425
Suzuki, Hara, Quercetin enhances intestinal barrier function through the assembly of zonula [corrected] occludens-2, occludin, and claudin-1 and the expression of claudin-4 in Caco-2 cells, J. Nutr, doi:10.3945/jn.108.100867
Suzuki, Hara, Role of flavonoids in intestinal tight junction regulation, J. Nutr. Biochem, doi:10.1016/j.jnutbio.2010.08.001
Torres-Flores, Arias, Tight junctions go viral!, Viruses, doi:10.3390/v7092865
Tripathi, Hazari, Mishra, Kumar, Sagi, Quercetin: a savior of alveolar barrier integrity under hypoxic microenvironment, Tissue Barriers, doi:10.1080/21688370.2021.1883963
Valenzano, Diguilio, Mercado, Teter, To et al., Remodeling of tight junctions and enhancement of barrier integrity of the CACO-2 intestinal epithelial cell layer by micronutrients, PLoS One, doi:10.1371/journal.pone.0133926
Virot, Mathien, Pointurier, Poidevin, Labro et al., Characterization of pulmonary impairment associated with COVID-19 in patients requiring mechanical ventilation, Rev. Bras. Ter. Intensiva, doi:10.5935/0103-507X.20210007
Wan, Winton, Soeller, Tovey, Gruenert et al., Der p 1 facilitates transepithelial allergen delivery by disruption of tight junctions, J. Clin. Invest, doi:10.1172/JCI5844
Xu, Qin, Xu, Yang, Chen et al., Dietary quercetin supplementation attenuates diarrhea, and intestinal damage by regulating gut microbiota in weanling piglets, Oxid. Med. Cell Longev, doi:10.1155/2021/6221012
Zhang, Li, Liu, Wang, Quercetin effectively improves LPS-induced intestinal inflammation, pyroptosis, and disruption of the barrier function through the TLR4/NF-κB/NLRP3 signaling pathway in vivo and <i>in vitro</i&gt, Food Nutr. Res, doi:10.29219/fnrv66.8948
Zhou, Xue, Jiang, Zhang, Wang et al., Beneficial effects of quercetin on microcystin-LR induced tight junction defects, Front. Pharmacol, doi:10.3389/fphar.2021.733993
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit